Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipoic acid injection for mild COVID-19
ChiCTR2000030471Phase 4Recruiting
- Sponsor
- Maoming People's Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of alpha-lipoic acid in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Maoming People's Hospital. Primary endpoint: Progression rate from mild to critical/severe COVID-19. Started Mar 2020; status: recruiting.
02
Drugs
alpha-lipoic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2000030471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030471.